- Home
- Publications
- Publication Search
- Publication Details
Title
The past, present, and future of antibiotics
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 14, Issue 657, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-08-11
DOI
10.1126/scitranslmed.abo7793
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
- (2022) Christopher JL Murray et al. LANCET
- Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's disease
- (2022) Walter Reinisch et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Author Correction: Development of spirulina for the manufacture and oral delivery of protein therapeutics
- (2022) Benjamin W. Jester et al. NATURE BIOTECHNOLOGY
- Design and Syntheses of New Antibiotics Inspired by Nature’s Quest for Iron in an Oxidative Climate
- (2021) Marvin J. Miller et al. ACCOUNTS OF CHEMICAL RESEARCH
- Discovery of Macrolide Antibiotics Effective against Multi-Drug Resistant Gram-Negative Pathogens
- (2021) Andrew G. Myers et al. ACCOUNTS OF CHEMICAL RESEARCH
- Unlocking the potential of antibody–drug conjugates for cancer therapy
- (2021) Joshua Z. Drago et al. Nature Reviews Clinical Oncology
- Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs)
- (2021) Gabrielle S. Dijksteel et al. Frontiers in Microbiology
- Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria
- (2021) David T. Davies et al. ACCOUNTS OF CHEMICAL RESEARCH
- Sewage and sewage-contaminated environments are the most prominent sources to isolate phages against Pseudomonas aeruginosa
- (2021) Bahareh Lashtoo Aghaee et al. BMC MICROBIOLOGY
- Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial
- (2021) Bruno François et al. LANCET INFECTIOUS DISEASES
- FDA approves 100th monoclonal antibody product
- (2021) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics
- (2021) Cornelis H. van Werkhoven et al. Nature Communications
- Bispecific Antibodies: From Research to Clinical Application
- (2021) Jiabing Ma et al. Frontiers in Immunology
- Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward
- (2021) Amila K. Nanayakkara et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cefiderocol: A new cephalosporin stratagem against multidrug resistant gram-negative bacteria
- (2021) Sharon Ong’uti et al. CLINICAL INFECTIOUS DISEASES
- The urgent need for metallo-β-lactamase inhibitors: an unattended global threat
- (2021) Maria F Mojica et al. LANCET INFECTIOUS DISEASES
- Rational design of a new antibiotic class for drug-resistant infections
- (2021) Thomas F. Durand-Reville et al. NATURE
- Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection
- (2021) Rebekah M. Dedrick et al. NATURE MEDICINE
- Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?
- (2021) Abigail R. Colson et al. VALUE IN HEALTH
- Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam
- (2021) Adam B. Shapiro et al. Frontiers in Microbiology
- Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner
- (2021) Emmanuel Montassier et al. Nature Microbiology
- Advances in Bacteriophage Therapy against Relevant MultiDrug-Resistant Pathogens
- (2021) Antonio Broncano-Lavado et al. Antibiotics-Basel
- Antivirulence Bispecific Monoclonal Antibody-Mediated Protection against Pseudomonas aeruginosa Ventilator-Associated Pneumonia in a Rabbit Model
- (2021) Fábio Aguiar-Alves et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The impact of human vaccines on bacterial antimicrobial resistance. A review
- (2021) Kathrin U. Jansen et al. Environmental Chemistry Letters
- A synthetic antibiotic class overcoming bacterial multidrug resistance
- (2021) Matthew J. Mitcheltree et al. NATURE
- Engineering living therapeutics with synthetic biology
- (2021) Andres Cubillos-Ruiz et al. NATURE REVIEWS DRUG DISCOVERY
- Multi-species host range of staphylococcal phages isolated from wastewater
- (2021) Pauline C. Göller et al. Nature Communications
- A Deep Learning Approach to Antibiotic Discovery
- (2020) Jonathan M. Stokes et al. CELL
- Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling
- (2020) Elizabeth J. Culp et al. NATURE
- Antimicrobial host defence peptides: functions and clinical potential
- (2020) Neeloffer Mookherjee et al. NATURE REVIEWS DRUG DISCOVERY
- Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercialization
- (2020) Kevin Outterson et al. Translational Research
- Childhood vaccines and antibiotic use in low- and middle-income countries
- (2020) Joseph A. Lewnard et al. NATURE
- Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017
- (2020) John A. Jernigan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-cMet Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC
- (2020) Jiyeon Yun et al. Cancer Discovery
- Zoliflodacin: An Oral Spiropyrimidinetrione Antibiotic for the Treatment of Neisseria gonorrheae, Including Multi-Drug-Resistant Isolates
- (2020) Patricia A. Bradford et al. ACS Infectious Diseases
- Antibacterial R&D at a crossroads: We’ve pushed as hard as we can … now we need to start pulling!
- (2020) John H Rex et al. CLINICAL INFECTIOUS DISEASES
- Biology of antimicrobial resistance and approaches to combat it
- (2020) Sarah M. Schrader et al. Science Translational Medicine
- Pharmacodynamic Evaluation of MRX-8, a Novel Polymyxin, in the Neutropenic Mouse Thigh and Lung Infection Models against Gram-Negative Pathogens
- (2020) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Receptor-targeted engineered probiotics mitigate lethal Listeria infection
- (2020) Rishi Drolia et al. Nature Communications
- The Preclinical and Clinical Progress of Bacteriophages and Their Lytic Enzymes: The Parts are Easier than the Whole
- (2019) Karim Abdelkader et al. Viruses-Basel
- Once-Daily Plazomicin for Complicated Urinary Tract Infections
- (2019) Florian M.E. Wagenlehner et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase 1, randomized, single ascending-dose study to investigate the safety, tolerability, and pharmacokinetics of DSTA4637S, an anti-Staphylococcus aureus THIOMAB™ antibody-antibiotic conjugate, in healthy volunteers
- (2019) Melicent Peck et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Engineering of Bacteriophages Against Infectious Diseases
- (2019) Yibao Chen et al. Frontiers in Microbiology
- Probiotics and prebiotics in intestinal health and disease: from biology to the clinic
- (2019) Mary Ellen Sanders et al. Nature Reviews Gastroenterology & Hepatology
- Treatment for extreme drug-resistant tuberculosis wins US government approval
- (2019) Amy Maxmen NATURE
- DRAMP 2.0, an updated data repository of antimicrobial peptides
- (2019) Xinyue Kang et al. Scientific Data
- MRSA dynamic circulation between the community and the hospital setting: New insights from a cohort study
- (2019) Danilo Barcudi et al. JOURNAL OF INFECTION
- A new antibiotic selectively kills Gram-negative pathogens
- (2019) Yu Imai et al. NATURE
- Antibiotic development — economic, regulatory and societal challenges
- (2019) Christine Årdal et al. NATURE REVIEWS MICROBIOLOGY
- The global preclinical antibacterial pipeline
- (2019) Ursula Theuretzbacher et al. NATURE REVIEWS MICROBIOLOGY
- The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics
- (2018) Michelle F. Richter et al. Annals of the New York Academy of Sciences
- MEDI3902 Correlates of Protection against Severe Pseudomonas aeruginosa Pneumonia in a Rabbit Acute Pneumonia Model
- (2018) Hoan N. Le et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phages & antibiotic resistance: are the most abundant entities on earth ready for a comeback?
- (2018) Colin Hill et al. Future Microbiology
- Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial
- (2018) Bruno François et al. INTENSIVE CARE MEDICINE
- KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa
- (2018) R. Jain et al. Journal of Cystic Fibrosis
- Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe
- (2018) Mike Sharland et al. LANCET INFECTIOUS DISEASES
- The FDA Animal Rule and its role in protecting human safety
- (2018) Theresa Allio Expert Opinion On Drug Safety
- IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs. Meropenem in the Treatment of Complicated Intra-Abdominal Infections
- (2018) Joseph S Solomkin et al. CLINICAL INFECTIOUS DISEASES
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance
- (2017) Jonathan M. Stokes et al. Nature Microbiology
- Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax
- (2016) Brent J. Yamamoto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine
- (2016) Sara Tomczyk et al. CLINICAL INFECTIOUS DISEASES
- Development of a platform for the discovery and practical synthesis of new tetracycline antibiotics
- (2016) Fan Liu et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Innovation in the pharmaceutical industry: New estimates of R&D costs
- (2016) Joseph A. DiMasi et al. JOURNAL OF HEALTH ECONOMICS
- A robust platform for chemical genomics in bacterial systems
- (2016) Shawn French et al. MOLECULAR BIOLOGY OF THE CELL
- Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
- (2016) Gerard D. Wright TRENDS IN MICROBIOLOGY
- Antibiotics: the changing regulatory and pharmaceutical industry paradigm
- (2015) Richard Bax et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A new antibiotic kills pathogens without detectable resistance
- (2015) Losee L. Ling et al. NATURE
- ESKAPEing the labyrinth of antibacterial discovery
- (2015) Ruben Tommasi et al. NATURE REVIEWS DRUG DISCOVERY
- Helping Chemists Discover New Antibiotics
- (2015) Mark A. T. Blaskovich et al. ACS Infectious Diseases
- Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning
- (2015) Jan Wildenhain et al. Cell Systems
- A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
- (2014) A. DiGiandomenico et al. Science Translational Medicine
- ComparativeIn VitroActivities of SMT19969, a New Antimicrobial Agent, against Clostridium difficile and 350 Gram-Positive and Gram-Negative Aerobic and Anaerobic Intestinal Flora Isolates
- (2013) Ellie J. C. Goldstein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of Protein A in the Evasion of Host Adaptive Immune Responses by Staphylococcus aureus
- (2013) F. Falugi et al. mBio
- Inhibition of WTA Synthesis Blocks the Cooperative Action of PBPs and Sensitizes MRSA to β-Lactams
- (2012) Maya A. Farha et al. ACS Chemical Biology
- Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa
- (2012) Bruno François et al. CRITICAL CARE MEDICINE
- Recover the lost art of drug discovery
- (2012) Kim Lewis NATURE
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
- (2011) Linda Ejim et al. Nature Chemical Biology
- How to improve R&D productivity: the pharmaceutical industry's grand challenge
- (2010) Steven M. Paul et al. NATURE REVIEWS DRUG DISCOVERY
- The natural history of antibiotics
- (2009) Jon Clardy et al. CURRENT BIOLOGY
- Raxibacumab for the Treatment of Inhalational Anthrax
- (2009) Thi-Sau Migone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acinetobacter baumanniiSkin and Soft‐Tissue Infection Associated with War Trauma
- (2008) Peter J. Sebeny et al. CLINICAL INFECTIOUS DISEASES
- Acinetobacter baumannii: Emergence of a Successful Pathogen
- (2008) A. Y. Peleg et al. CLINICAL MICROBIOLOGY REVIEWS
- Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
- (2008) Rosemarie O’Shea et al. JOURNAL OF MEDICINAL CHEMISTRY
- Combination chemical genetics
- (2008) Joseph Lehár et al. Nature Chemical Biology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started